Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc.

Cell | Mar 5, 2010

http://www.ncbi.nlm.nih.gov/pubmed/20211139

Angelman Syndrome is a debilitating neurological disorder caused by mutation of the E3 ubiquitin ligase Ube3A, a gene whose mutation has also recently been associated with autism spectrum disorders (ASDs). The function of Ube3A during nervous system development and how Ube3A mutations give rise to cognitive impairment in individuals with Angleman Syndrome and ASDs are not clear. We report here that experience-driven neuronal activity induces Ube3A transcription and that Ube3A then regulates excitatory synapse development by controlling the degradation of Arc, a synaptic protein that promotes the internalization of the AMPA subtype of glutamate receptors. We find that disruption of Ube3A function in neurons leads to an increase in Arc expression and a concomitant decrease in the number of AMPA receptors at excitatory synapses. We propose that this deregulation of AMPA receptor expression at synapses may contribute to the cognitive dysfunction that occurs in Angelman Syndrome and possibly other ASDs.

Pubmed ID: 20211139 RIS Download

Mesh terms: Angelman Syndrome | Animals | Cells, Cultured | Cognition | Cytoskeletal Proteins | Humans | Mice | Mice, Knockout | Nerve Tissue Proteins | Receptors, AMPA | Synapses | Ubiquitin-Protein Ligases | Ubiquitination

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIMH NIH HHS, Id: MH53608
  • Agency: NINDS NIH HHS, Id: NS28829
  • Agency: NINDS NIH HHS, Id: R01 NS028829
  • Agency: NINDS NIH HHS, Id: R01 NS028829-19
  • Agency: NINDS NIH HHS, Id: R01 NS028829-20
  • Agency: NINDS NIH HHS, Id: R01 NS028829-21
  • Agency: NINDS NIH HHS, Id: R01 NS028829-21S1

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.